about
Age-dependent contribution of Rho kinase in carbachol-induced contraction of human detrusor smooth muscle in vitroMedical management of overactive bladderPharmacodynamics of propiverine and three of its main metabolites on detrusor contractionIntravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result.Management of Catheter-Related Bladder Discomfort in Patients Who Underwent Elective Surgery.Nocturia in relation to sleep, health, and medical treatment in the elderly.Neuromodulation for the treatment of urinary incontinence.Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin.Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive BladderNocturia × disturbed sleep: a review.Systematic review of the relationship between bladder and bowel function: implications for patient management.Neuromodulation for the Treatment of Lower Urinary Tract Symptoms.Comparison between ketamine and hyoscine for the management of postoperative catheter-related bladder discomfort: A randomized controlled double-blind studyTrends in Pharmacotherapy for Bladder Dysfunction Among Children in the United States, 2000 to 2013.Randomized, Single-Blind, Parallel Study of the Effectiveness and Safety of Solifenacin versus Propiverine in the Treatment of Overactive Bladder.Cholinergic-induced Ca2+ signaling in interstitial cells of Cajal from the guinea pig bladder.Interstitial cells and cholinergic signalling in the outer muscle layers of the guinea-pig bladder.Effect of morphine on lower urinary tract discomfort after transurethral resection of prostate under general anesthesia: a randomised clinical study.The effects of tolterodine on bladder-filling sensations and perception thresholds to intravesical electrical stimulation: method and initial results.Cholinergic activation of phasic activity in the isolated bladder: possible evidence for M3- and M2-dependent components of a motor/sensory system.Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.
P2860
Q33823666-EB4E1EFD-4F92-4A67-A045-1256ABC9E60CQ34124065-B65088AE-7560-431B-A787-BEE858FC3C32Q35048983-E57CF3D3-EBE5-4D28-AE3B-E4437C7E4CCBQ35813307-FA939C23-0E59-40FD-AD18-840B10D83D76Q35814327-DE52A51F-3D05-4162-9A60-477F540AE9E6Q36219827-9F49A4E3-CBE6-4D57-86D1-214D10A67EF3Q37181397-0E83DA7C-2C27-4545-95FC-7FA92C8D071EQ37192944-CD9945FD-E2E7-4553-9102-4C2388F5CFEEQ37290722-8E063CCD-5FF2-481E-BA22-198FC2EC497DQ37952599-D8DE969F-40CF-46AF-AF9B-52099D7285AAQ38081463-57D868DE-8A35-4BF1-9B6C-6759097AE569Q38668454-F19AD9FC-F448-4FB4-A7E3-8304CEFC1CE5Q38835049-FEF970F8-0856-4349-A6B3-A4EB4E7A2DC2Q39853460-FE3D014A-D0BD-41F2-AB68-B21AFA9DC180Q40216118-41F22A24-47AE-4451-A1F7-66EA90096D37Q41932938-A8EC24A6-F9DD-499F-AC1A-C3EFA927E762Q46551462-60581B69-84C7-4F5F-B395-A8E794A4558BQ48025029-0B16D807-0A33-482E-88DB-2ECE43871439Q51743958-2BB42DFD-CDDE-46E0-85BE-C4EA1873ED7EQ51746424-E18A4256-BCA2-43A7-972D-639C72536F38Q51813680-0C3AF0DE-500E-41C9-BC39-64295B08EE0E
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Which muscarinic receptor is important in the bladder?
@ast
Which muscarinic receptor is important in the bladder?
@en
Which muscarinic receptor is important in the bladder?
@nl
type
label
Which muscarinic receptor is important in the bladder?
@ast
Which muscarinic receptor is important in the bladder?
@en
Which muscarinic receptor is important in the bladder?
@nl
prefLabel
Which muscarinic receptor is important in the bladder?
@ast
Which muscarinic receptor is important in the bladder?
@en
Which muscarinic receptor is important in the bladder?
@nl
P356
P1476
Which muscarinic receptor is important in the bladder?
@en
P2093
T Yamanishi
P2888
P304
P356
10.1007/S003450100226
P577
2001-11-01T00:00:00Z
P6179
1048746944